NTLA Q1 2026 Earnings Narrowerthanexpected loss signals continued progress in gene editing pipeline Biohaven BHVN Q1 2026 Earnings EPS Slightly Misses Estimates as Pipeline Momentum Builds MBRX Q1 2026 Earnings EPS Misses Estimates Widely Stock Rises on Speculative Momentum CRGO Q4 2025 Earnings NarrowerthanExpected Loss Despite Macro Headwinds RLI Q1 2026 Earnings EPS Beats Estimates by Nearly 5 Shares Edge Lower